Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Anne, Dib"'
Autor:
Bruno Guerci, Francesco Giorgino, Hélène Sapin, Kristina Boye, Jérémie Lebrec, Marco Orsini Federici, Elke Heitmann, Anne Dib, Martin Füchtenbusch, Luis‐Emilio García‐Pérez
Publikováno v:
Diabetes, Obesity and Metabolism. 24:2373-2382
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7c8fbdd5e0814484d411df4b85cf94f
https://doi.org/10.1111/dom.14823
https://doi.org/10.1111/dom.14823
Autor:
Francesco Giorgino, Bruno Guerci, Luis-Emilio García-Pérez, Martin Füchtenbusch, Jeremie Lebrec, Marco Orsini Federici, Anne Dib, Elke Heitmann, Maria Yu, Kristina Boye
Publikováno v:
Diabetologie und Stoffwechsel.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16d569e8257d42fa4026f72f0be8df84
https://doi.org/10.1055/s-0043-1767871
https://doi.org/10.1055/s-0043-1767871
Autor:
Bruno, Guerci, Francesco, Giorgino, Hélène, Sapin, Kristina, Boye, Jérémie, Lebrec, Marco Orsini, Federici, Elke, Heitmann, Anne, Dib, Martin, Füchtenbusch, Luis-Emilio, García-Pérez
Publikováno v:
Diabetes, obesitymetabolism. 24(12)
The primary objective of the TROPHIES observational study is to estimate the duration of treatment on dulaglutide or liraglutide without a significant treatment change by 24 months in patients with type 2 diabetes (T2D) initiating their first injecta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2ad61c4515541a2e700d5dd3e4d25475
https://pubmed.ncbi.nlm.nih.gov/35876235
https://pubmed.ncbi.nlm.nih.gov/35876235
Autor:
BRUNO GUERCI, FRANCESCO GIORGINO, KRISTINA BOYE, MARTIN FUECHTENBUSCH, ELKE HEITMANN, JEREMIE LEBREC, ANNE DIB, MARCO ORSINI FEDERICI, MARIA YU, LUIS-EMILIO GARCIA-PEREZ
Publikováno v:
Diabetes. 71
TROPHIES was a 24-month, prospective, non-comparative, observational study in adult patients with T2D initiating their first injectable glucose-lowering treatment with once-weekly dulaglutide (DU; N=1,014) or once-daily liraglutide (LIRA; N=991) in F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b64a216d9eca0f53ff290145fe234612
https://doi.org/10.2337/db22-726-p
https://doi.org/10.2337/db22-726-p
Autor:
FRANCESCO GIORGINO, BRUNO GUERCI, LUIS-EMILIO GARCIA-PEREZ, MARTIN FUECHTENBUSCH, JEREMIE LEBREC, MARCO ORSINI FEDERICI, ANNE DIB, ELKE HEITMANN, MARIA YU, KRISTINA BOYE
Publikováno v:
Diabetes. 71
TROPHIES was a 24-month, prospective, non-comparative, observational study in adult patients with T2D initiating their first injectable glucose-lowering treatment with once-weekly dulaglutide (DU; N=1,014) or once-daily liraglutide (LIRA; N=991) in F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c39fe6c90eb45b6631c1d22d7a979258
https://doi.org/10.2337/db22-746-p
https://doi.org/10.2337/db22-746-p
Autor:
MARTIN FUECHTENBUSCH, BRUNO GUERCI, FRANCESCO GIORGINO, LUIS-EMILIO GARCIA-PEREZ, ELKE HEITMANN, JEREMIE LEBREC, ANNABEL BARRETT, ANNE DIB, MARCO ORSINI FEDERICI, KRISTINA BOYE
Publikováno v:
Diabetes. 71
Data on patient-reported outcome (PRO) measures in people living with T2D who initiate injectable glucagon-like peptide-1 receptor agonist (GLP-1 RA) medication in routine clinical practice are limited. Here we present final PRO data from the TROPHIE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f5e8e06eb9893cb260968c41a07c9a2
https://doi.org/10.2337/db22-738-p
https://doi.org/10.2337/db22-738-p
Autor:
null Bruno Guerci, null Francesco Giorgino, null Hélène Sapin, null Kristina Boye, null Jérémie Lebrec, null Marco Orsini Federici, null Elke Heitmann, null Anne Dib, null Martin Füchtenbusch, null Luis‐Emilio García‐Pérez
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7074bb685d14026d33ff6aae63124b46
https://doi.org/10.1111/dom.14823/v2/response1
https://doi.org/10.1111/dom.14823/v2/response1
Autor:
Bruno Guerci, Francesco Giorgino, Luis-Emilio García-Pérez, Kristina Boye, Kirsi Norrbacka, Helene Sapin, Elke Heitmann, Jeremie Lebrec, Anne Dib, Marco Orsini Federici, Martin Füchtenbusch
Publikováno v:
Hand in Hand zum Ziel – einfach.besser.messbar www.diabeteskongress.de.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e3c86dc36298d20178287c753f5cd33
https://doi.org/10.1055/s-0042-1746272
https://doi.org/10.1055/s-0042-1746272
Autor:
Melanie Noel, Kathryn A. Birnie, Dolores Pahtayken, Katherine Dib, Kimberly Nelson, Jill Chorney, Mary Anne Dib, Carley Ouellette, Paula Forgeron, Patricia Poulin, Jennifer Stinson, Krista Baerg, Christine Lamontagne
Publikováno v:
CMAJ open. 7(4)
Background Chronic pain affects 1-3 million Canadian children and adolescents and their families. The primary objective of the Partnering For Pain project was to collaboratively identify the top 10 research priorities in pediatric chronic pain. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25768e284d93f0a6b688407e85639d32
https://pubmed.ncbi.nlm.nih.gov/31699686
https://pubmed.ncbi.nlm.nih.gov/31699686
Autor:
Nathalie Parquet, Anne Dib-Deperrest, Elif Hindié, Pascal Houzé, Jean-Luc Moretti, Marie-Elisabeth Toubert
Publikováno v:
Thyroid. 18:469-472
Amiodarone has a high iodine content that can induce persistent iodine excess and may prevent radioiodine (RI) treatment.A 55-year-old obese man had taken amiodarone (200 mg/d) for 3 years and stopped 2 years earlier. He underwent total thyroidectomy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::796861d02974f4f8c704d390fc2c7df8
https://doi.org/10.1089/thy.2007.0184
https://doi.org/10.1089/thy.2007.0184